The NPA responded to the Scottish Government consultation looking at the development of a Patient Safety Commissioner Role for Scotland
The Cumberledge Review, published in July 2020 recommended how healthcare in England could respond more effectively to concerns on safety of medicines and medical devices. Scottish Government also agreed to put all recommendations from the review in place including the Patient Safety Commissioner role.
The NPA response supported the new role to champion the value of listening to patients and promoting user perspectives in seeking improvements to patient safety around the use of medicines and medical devices.
We commented that sharing of experience across health professionals is vital to quality improvement and should be facilitated wherever possible, including between UK countries. We described the patient safety culture of community pharmacy, and offered to provide evidence of the safety of independent community pharmacy to Government. We also called for no additional bureaucracy to be applied to members in the implementation of the development of the role and surrounding governance.
Read the NPA response here.